{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:19:54Z","timestamp":1787829594999,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-03034-8","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:34:57Z","timestamp":1787826897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between visceral adiposity index and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes mellitus: an exploratory cross-sectional study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-6329","authenticated-orcid":false,"given":"A.","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Morandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giachetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Molinaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bongiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Capoccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"3034_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher G, Valenti L, Byrne CD (2025) Metabolic Dysfunction\u2013Associated Steatotic Liver Disease. N Engl J Med 393:683\u2013698. https:\/\/doi.org\/10.1056\/NEJMra2412865","journal-title":"N Engl J Med"},{"key":"3034_CR2","doi-asserted-by":"publisher","unstructured":"Feng G, Targher G, Byrne CD et al (2025) Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Rep 7. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101271","DOI":"10.1016\/j.jhepr.2024.101271"},{"key":"3034_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Price JK et al (2024) The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes. Clin Gastroenterol Hepatol 22:1999\u20132010 e8. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3034_CR4","doi-asserted-by":"publisher","unstructured":"Mantovani A, Morandin R, Rolli N et al Bidirectional relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus. EXCLI J 25:803\u2013821. https:\/\/doi.org\/10.17179\/excli2026-9462","DOI":"10.17179\/excli2026-9462"},{"key":"3034_CR5","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.cgh.2024.09.038","volume":"23","author":"M Souza","year":"2025","unstructured":"Souza M, Al-Sharif L, Khalil SM et al (2025) Global Epidemiology and Characteristics of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 1 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 23:1308\u20131319e17. https:\/\/doi.org\/10.1016\/j.cgh.2024.09.038","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3034_CR6","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1111\/dom.16333","volume":"27","author":"M Vergani","year":"2025","unstructured":"Vergani M, Borella ND, Rizzo M et al (2025) Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study. Diabetes Obes Metab 27:3201\u20133211. https:\/\/doi.org\/10.1111\/dom.16333","journal-title":"Diabetes Obes Metab"},{"key":"3034_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s40618-025-02621-5","volume":"48","author":"JL Herrera-Ojeda","year":"2025","unstructured":"Herrera-Ojeda JL, Blanco-Palma RS, Ch\u00e1vez-Tapia NC et al (2025) The pathophysiological link between type 1 diabetes and MASLD: insights into insulin resistance and liver dysfunction. J Endocrinol Invest 48:2279\u20132293. https:\/\/doi.org\/10.1007\/s40618-025-02621-5","journal-title":"J Endocrinol Invest"},{"key":"3034_CR8","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3390\/nu17142374","volume":"17","author":"GK Jakubiak","year":"2025","unstructured":"Jakubiak GK, Badicu G, Surma S et al (2025) The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders. Nutrients 17:2374. https:\/\/doi.org\/10.3390\/nu17142374","journal-title":"Nutrients"},{"key":"3034_CR9","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.3390\/jcm14103405","volume":"14","author":"R Bende","year":"2025","unstructured":"Bende R, Heredea D, Ra\u021biu I et al (2025) Association Between Visceral Adiposity and the Prediction of Hepatic Steatosis and Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). J Clin Med 14:3405. https:\/\/doi.org\/10.3390\/jcm14103405","journal-title":"J Clin Med"},{"key":"3034_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-45869-4","author":"\u0130 Solmaz","year":"2026","unstructured":"Solmaz \u0130, K\u0131r\u0131k A, Demir \u0130 et al (2026) The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-026-45869-4","journal-title":"Sci Rep"},{"key":"3034_CR11","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1111\/liv.13941","volume":"38","author":"C Xu","year":"2018","unstructured":"Xu C, Ma Z, Wang Y et al (2018) Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up. Liver Int 38:2294\u20132300. https:\/\/doi.org\/10.1111\/liv.13941","journal-title":"Liver Int"},{"key":"3034_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.clinre.2019.04.002","volume":"44","author":"T Okamura","year":"2020","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M et al (2020) The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study. Clin Res Hepatol Gastroenterol 44:375\u2013383. https:\/\/doi.org\/10.1016\/j.clinre.2019.04.002","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3034_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12876-025-03957-1","volume":"25","author":"T Zhou","year":"2025","unstructured":"Zhou T, Ding X, Chen L et al (2025) Visceral adiposity index as a predictor of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study. BMC Gastroenterol 25:326. https:\/\/doi.org\/10.1186\/s12876-025-03957-1","journal-title":"BMC Gastroenterol"},{"key":"3034_CR14","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/biomedicines9121890","volume":"9","author":"A Ismaiel","year":"2021","unstructured":"Ismaiel A, Jaaouani A, Leucuta D-C et al (2021) The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis\u2014Systematic Review and Meta-Analysis. Biomedicines 9:1890. https:\/\/doi.org\/10.3390\/biomedicines9121890","journal-title":"Biomedicines"},{"key":"3034_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1177\/00099228261417527","volume":"65","author":"S Albayrak","year":"2026","unstructured":"Albayrak S, Karaoglan M, Yildirim A et al (2026) Visceral Adiposity Index as a Predictor of Metabolic Syndrome in Children and Adolescents With Type 1 Diabetes: A Cross-Sectional Study. Clin Pediatr (Phila) 65:856\u2013868. https:\/\/doi.org\/10.1177\/00099228261417527","journal-title":"Clin Pediatr (Phila)"},{"key":"3034_CR16","doi-asserted-by":"publisher","first-page":"e70514","DOI":"10.1111\/liv.70514","volume":"46","author":"A Mantovani","year":"2026","unstructured":"Mantovani A, Scoccia E, Morandin R et al (2026) MASLD in Adults With Type 1 Diabetes and Type 2 Diabetes Undergoing Vibration-Controlled Transient Elastography. Liver Int 46:e70514. https:\/\/doi.org\/10.1111\/liv.70514","journal-title":"Liver Int"},{"key":"3034_CR17","doi-asserted-by":"publisher","first-page":"101684","DOI":"10.1016\/j.diabet.2025.101684","volume":"51","author":"A Mantovani","year":"2025","unstructured":"Mantovani A, Ciardullo S, Sani E et al (2025) Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study. Diabetes Metab 51:101684. https:\/\/doi.org\/10.1016\/j.diabet.2025.101684","journal-title":"Diabetes Metab"},{"key":"3034_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB SAUNDERS","year":"1993","unstructured":"SAUNDERS JB, AASLAND OG, BABOR TF et al (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 88:791\u2013804. https:\/\/doi.org\/10.1111\/j.1360-0443.1993.tb02093.x","journal-title":"Addiction"},{"key":"3034_CR19","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ et al (2024) KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 105:S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"3034_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.kisu.2017.10.003","volume":"8","author":"F Persson","year":"2018","unstructured":"Persson F, Rossing P (2018) Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl 8:2\u20137. https:\/\/doi.org\/10.1016\/j.kisu.2017.10.003","journal-title":"Kidney Int Suppl"},{"key":"3034_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M et al (2010) Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33:920\u2013922. https:\/\/doi.org\/10.2337\/dc09-1825","journal-title":"Diabetes Care"},{"key":"3034_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke F, Horn P, Wong VW-S et al (2024) EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"key":"3034_CR23","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M et al (2019) Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 156:1717\u20131730. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042","journal-title":"Gastroenterology"},{"key":"3034_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","volume":"23","author":"W Bielka","year":"2024","unstructured":"Bielka W, Przezak A, Mol\u0119da P et al (2024) Double diabetes\u2014when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovasc Diabetol 23:62. https:\/\/doi.org\/10.1186\/s12933-024-02145-x","journal-title":"Cardiovasc Diabetol"},{"key":"3034_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13300-017-0333-9","volume":"9","author":"G Priya","year":"2018","unstructured":"Priya G, Kalra S (2018) A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin? Diabetes Ther 9:349\u2013361. https:\/\/doi.org\/10.1007\/s13300-017-0333-9","journal-title":"Diabetes Ther"},{"key":"3034_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.111.077487","volume":"127","author":"JQ Purnell","year":"2013","unstructured":"Purnell JQ, Zinman B, Brunzell JD (2013) The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus. Circulation 127:180\u2013187. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.077487","journal-title":"Circulation"},{"key":"3034_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jpeds.2012.07.036","volume":"162","author":"BJ Specht","year":"2013","unstructured":"Specht BJ, Wadwa RP, Snell-Bergeon JK et al (2013) Estimated Insulin Sensitivity and Cardiovascular Disease Risk Factors in Adolescents with and without Type 1 Diabetes. J Pediatr 162:297\u2013301. https:\/\/doi.org\/10.1016\/j.jpeds.2012.07.036","journal-title":"J Pediatr"},{"key":"3034_CR28","doi-asserted-by":"crossref","unstructured":"Chait A, den Hartigh LJ (2020) Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front Cardiovasc Med Volume 7-2020","DOI":"10.3389\/fcvm.2020.00022"},{"key":"3034_CR29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"3034_CR30","doi-asserted-by":"publisher","first-page":"18575","DOI":"10.1038\/s41598-020-75667-5","volume":"10","author":"EB Parente","year":"2020","unstructured":"Parente EB, Mutter S, Harjutsalo V et al (2020) Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes. Sci Rep 10:18575. https:\/\/doi.org\/10.1038\/s41598-020-75667-5","journal-title":"Sci Rep"},{"key":"3034_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/15578518261419363","volume":"24","author":"N Janakiram","year":"2026","unstructured":"Janakiram N, Puri S, Thirumalai A (2026) Waist Circumference as a Predictor of Hepatic Steatosis and Fibrosis in the NHANES 2017\u20132018 Cohort. Metab Syndr Relat Disord 24:112\u2013120. https:\/\/doi.org\/10.1177\/15578518261419363","journal-title":"Metab Syndr Relat Disord"},{"key":"3034_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijcard.2016.10.040","volume":"225","author":"A Mantovani","year":"2016","unstructured":"Mantovani A, Mingolla L, Rigolon R et al (2016) Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes. Int J Cardiol 225:387\u2013391. https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.040","journal-title":"Int J Cardiol"},{"key":"3034_CR33","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2337\/dc13-2704","volume":"37","author":"G Targher","year":"2014","unstructured":"Targher G, Mantovani A, Pichiri I et al (2014) Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. Diabetes Care 37:1729\u20131736. https:\/\/doi.org\/10.2337\/dc13-2704","journal-title":"Diabetes Care"},{"key":"3034_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jdiacomp.2017.01.024","volume":"31","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Rigolon R, Mingolla L et al (2017) Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. J Diabetes Complications 31:1021\u20131026. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.01.024","journal-title":"J Diabetes Complications"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03034-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:34:58Z","timestamp":1787826898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-03034-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":34,"alternative-id":["3034"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-03034-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical standards of the Helsinki Declaration (1975 and subsequent revisions) (\n                      \n                      ) and the study protocol was approved by the local Institutional Ethics Committees.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each participant.","order":2,"name":"Ethics","label":"Informed consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors had any significant conflicts of interest with respect to this study.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}